Efficacy of the CCR5 Antagonist Maraviroc in Reducing Early,...

Correspondence to Franco Baldelli, MD, Clinica Malattie Infettive, Ospedale S. Maria della Misericordia, Piazzale Menghini 1, 06129 Perugia, Italy.

http://circ.ahajournals.org/content/127/21/2114.short?rss=1